Feb 13, 2018· Comment from Association for Accessible Medicines· FDA-2017-D-6352-0719
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding Docket FDA-2017-D-6352-0001: Gluten in Drug Products and Associated Labeling Recommendations.